Changes

'''Gardasil''' is a controversial [[vaccine]], recently made available by [[Merck]] to prevent infection with the human papillomavirus (HPV) in girls and women ages 9 to 26.<ref>[http://www.gardasil.com/who-should-receive-gardasil.html Who should recieve Gardasil?], Merck official website.</ref> <ref>The vaccine is designed to protect against types 6, 11, 16 and 18 of HPV.</ref>  

'''Gardasil''' is a controversial [[vaccine]], recently made available by [[Merck]] to prevent infection with the human papillomavirus (HPV) in girls and women ages 9 to 26.<ref>[http://www.gardasil.com/who-should-receive-gardasil.html Who should recieve Gardasil?], Merck official website.</ref> <ref>The vaccine is designed to protect against types 6, 11, 16 and 18 of HPV.</ref>  

Proponents praise it as the first vaccine against cancer. Opponents say it will lead to sexual [[disinhibition]].

Proponents praise it as the first vaccine against cancer. Opponents say it will lead to sexual [[disinhibition]].<ref>The New Scientist in Britain quoted the Family Research Council's Bridget Maher warning that "giving the HPV vaccine to young women could be potentially harmful, because they may see it as a licence to engage in premarital sex." [http://www.time.com/time/nation/article/0,8599,1206813,00.html Defusing the War Over the "Promiscuity" Vaccine - TIME]</ref>

These strains of HPV are [[sexually transmitted diseases]] that are endemic among [[promiscuity|promiscuous]] people and have been associated with 70% of cervical cancer cases.  They may also play a role in the development of other types of cancer <ref>[http://www.cancer.gov/cancertopics/factsheet/Risk/HPV]</ref>. In June 2006, the U.S. [[Food and Drug Administration]] approved the first HPV vaccine without reviewing any epidemiological studies and monitoring for only a brief period the elevated [[antibody]] levels in recipients of the vaccine.<ref> http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm</ref>

These strains of HPV are [[sexually transmitted diseases]] that are endemic among [[promiscuity|promiscuous]] people and have been associated with 70% of cervical cancer cases.  They may also play a role in the development of other types of cancer <ref>[http://www.cancer.gov/cancertopics/factsheet/Risk/HPV]</ref>. In June 2006, the U.S. [[Food and Drug Administration]] approved the first HPV vaccine without reviewing any epidemiological studies and monitoring for only a brief period the elevated [[antibody]] levels in recipients of the vaccine.<ref> http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm</ref>